230 related articles for article (PubMed ID: 21789543)
1. Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.
Zinzani PL; Piccaluga PP
Curr Oncol Rep; 2011 Oct; 13(5):407-15. PubMed ID: 21789543
[TBL] [Abstract][Full Text] [Related]
2. Primary mediastinal large B-cell lymphoma.
Martelli M; Ferreri A; Di Rocco A; Ansuinelli M; Johnson PWM
Crit Rev Oncol Hematol; 2017 May; 113():318-327. PubMed ID: 28318892
[TBL] [Abstract][Full Text] [Related]
3. Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
Abramson JS
Cancer; 2019 Sep; 125(18):3111-3120. PubMed ID: 31287161
[TBL] [Abstract][Full Text] [Related]
4. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
5. Primary mediastinal B-cell lymphoma.
Johnson PW; Davies AJ
Hematology Am Soc Hematol Educ Program; 2008; ():349-58. PubMed ID: 19074109
[TBL] [Abstract][Full Text] [Related]
6. Primary mediastinal lymphoma: diagnosis and treatment options.
Martelli M; Di Rocco A; Russo E; Perrone S; Foà R
Expert Rev Hematol; 2015 Apr; 8(2):173-86. PubMed ID: 25537750
[TBL] [Abstract][Full Text] [Related]
7. Primary mediastinal large B-cell lymphoma.
Savage KJ
Blood; 2022 Sep; 140(9):955-970. PubMed ID: 34496020
[TBL] [Abstract][Full Text] [Related]
8. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
9. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.
Dabaja BS; Advani R; Hodgson DC; Dhakal S; Flowers CR; Ha CS; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP; Roberts KB; Shapiro R; Smith SM; Terezakis SA; Winkfield KM; Younes A; Constine LS
Am J Clin Oncol; 2015 Dec; 38(6):610-20. PubMed ID: 26583344
[TBL] [Abstract][Full Text] [Related]
10. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Hu S; Xu-Monette ZY; Balasubramanyam A; Manyam GC; Visco C; Tzankov A; Liu WM; Miranda RN; Zhang L; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Zhao X; Winter JN; Zhang M; Li L; Møller MB; Piris MA; Li Y; Go RS; Wu L; Medeiros LJ; Young KH
Blood; 2013 Apr; 121(14):2715-24. PubMed ID: 23343832
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy.
Xu LM; Fang H; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Ren H; Zhou LQ; Li YX
Leuk Lymphoma; 2013 Aug; 54(8):1684-90. PubMed ID: 23137070
[TBL] [Abstract][Full Text] [Related]
12. [The primary mediastinal lymphoma: state of the art and therapeutical perspectives].
Foppoli M; Citterio G; Donadoni G; Govi S; Ferreri AJ
Recenti Prog Med; 2013 May; 104(5):203-8. PubMed ID: 23748685
[TBL] [Abstract][Full Text] [Related]
13. The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients.
Broccoli A; Casadei B; Stefoni V; Pellegrini C; Quirini F; Tonialini L; Morigi A; Marangon M; Argnani L; Zinzani PL
BMC Cancer; 2017 Apr; 17(1):276. PubMed ID: 28415982
[TBL] [Abstract][Full Text] [Related]
14. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma.
Yang SH; Hsiao LT; Chiou TJ; Yang CF; Yu YB; Liu CY; Gau JP; Liu JH; Chen PM; Tzeng CH
J Chin Med Assoc; 2015 Jul; 78(7):400-7. PubMed ID: 25801492
[TBL] [Abstract][Full Text] [Related]
15. The unique biology and treatment of primary mediastinal B-cell lymphoma.
Broccoli A; Zinzani PL
Best Pract Res Clin Haematol; 2018 Sep; 31(3):241-250. PubMed ID: 30213393
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 82 cases of primary mediastinal large B cell lymphoma].
Wang J; Hu C; Zhao Y; Yi P; Huang M; Zhang G
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):491-4. PubMed ID: 24985169
[TBL] [Abstract][Full Text] [Related]
17. Primary large cell lymphoma of the mediastinum.
Aisenberg AC
Semin Oncol; 1999 Jun; 26(3):251-8. PubMed ID: 10375082
[TBL] [Abstract][Full Text] [Related]
18. Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ennishi D; Asai H; Maeda Y; Shinagawa K; Ikeda K; Yokoyama M; Terui Y; Takeuchi K; Yoshino T; Matsuo K; Hatake K; Tanimoto M
Ann Oncol; 2010 Jun; 21(6):1217-1221. PubMed ID: 19884246
[TBL] [Abstract][Full Text] [Related]
19. Advances in the management of primary mediastinal large B-cell lymphoma.
Advani RH
Clin Adv Hematol Oncol; 2018 Jan; 16(1):33-34. PubMed ID: 29741502
[No Abstract] [Full Text] [Related]
20. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
